Curaleaf Holdings Files 6-K for Q1 2025 Period

Ticker: CURLF · Form: 6-K · Filed: 2025-05-09T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing

TL;DR

Curaleaf filed a 6-K for Q1 2025, confirming 40-F annual reports and incorporating info into F-10.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on May 9, 2025, for the period ending March 31, 2025. The filing indicates that Curaleaf is a foreign private issuer and will file annual reports under Form 40-F. Exhibit 99.1 from this filing is incorporated by reference into their Form F-10 registration statement.

Why It Matters

This filing provides an update on Curaleaf's reporting status and incorporates information into their existing SEC filings, which is important for investors tracking the company's regulatory compliance and financial disclosures.

Risk Assessment

Risk Level: low — This is a routine filing that primarily concerns reporting status and incorporation by reference, with no new material financial or operational information disclosed.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of May 2025, and to incorporate Exhibit 99.1 into the Company's Form F-10 registration statement.

Which fiscal period does this report cover?

This report covers the period conformed as of March 31, 2025.

Does Curaleaf Holdings, Inc. file annual reports under Form 20-F or Form 40-F?

Curaleaf Holdings, Inc. files annual reports under Form 40-F, as indicated by the checkmark next to 'Form 40-F'.

What is the Commission File Number for Curaleaf Holdings, Inc.?

The Commission File Number for Curaleaf Holdings, Inc. is 333-249081.

Which registration statement is Exhibit 99.1 being incorporated into?

Exhibit 99.1 is being incorporated by reference into the Registration Statement on Form F-10, File No. 333-269109, of Curaleaf Holdings, Inc.

From the Filing

0001756770-25-000016.txt : 20250509 0001756770-25-000016.hdr.sgml : 20250509 20250508194447 ACCESSION NUMBER: 0001756770-25-000016 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250509 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 25927955 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 q1256-kcover.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ INCORPORATION BY REFERENCE Exhibit 99.1 to this Form 6-K of Curaleaf Holdings, Inc. (the “Company”) are hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-269109) of the Company, as amended or supplemented. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: May 8, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Unaudited Condensed Interim Consolidated Financial Statements as of March 31 , 202 5 and December 31, 202 4 and for the Three Months Ended March 31 , 202 5 and 202 4 and Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31 , 202 5 and 202 4 99.2 CEO Certification of Interim Filings 99.3 CFO Certification of Interim Filings 99.4 Press Release dated Ma y 8, 2025 EX-99.1 2 q125-exx992xfsandmda.htm EX-99.1 Document Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of March 31, 2025 and December 31, 2024 and For the Three Months Ended March 31, 2025 and 2024 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of March 31, 2025 and December 31, 2024 3 Condensed Interim Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2025 and 2024 5 Condensed Interim Consolidated Statements of Comprehensive Loss (Unaudited) for the three months ended March 31, 2025 and 2024 6 Condensed Interim Consolidated Statements of Temporary Equity and Shareholders’ Equity (Unaudited) for the three months ended March 31, 2025 and 2024 7 Condensed Interim Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2025 and 2024 8 Notes to Condensed Interim Consolidated Financial Statements (Unaudited) 10 Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three months ended March 31, 2025 and 2024 62 Curaleaf Holdings, Inc. Condensed Interim Consolidated Balance She

View on Read The Filing